Nanoscale biomaterials for terahertz imaging: A non-invasive approach for early cancer detection

•Terahertz (THz) technology can be employed as a non-invasive imaging for early detection and cancer diagnosis.•THz medical imaging detect changes in water content and structural variations to distinguish cancerous cells from normal tissues.•Nanoparticle contrast agents may enhance sensitivity and specificity of THz imaging. Terahertz (THz) technology is developing a non-invasive imaging system for biosensing and clinical diagnosis. THz medical imaging mainly benefits from great sensitivity in detecting changes in water content and structural variations in diseased cells versus normal tissues. Compared to healthy tissues, cancerous tumors contain a higher level of water molecules and show structural changes, resulting in different THz absorption. Here we described the principle of THz imaging and advancement in the field of translational biomedicine and early detection of pathologic tissue, with a particular focus on oncology. In addition, although the main forte of THz imaging relies on detecting differences in water content to distinguish the exact margin of tumor, THz displays limited contrast in living tissue for in-vivo clinical imaging. In the last few years, nanotechnology has attracted attention to aid THz medical imaging and various nanoparticles have been investigated as contrast enhancements to improve the accuracy, sensitivity, and specificity of THz images. Most of these multimodal contrast agents take advantage of the temperature-dependent of THz spectrum to the conformational variation of the water molecule. We discuss advances in developing THz contrast agents to accelerate the advancement of non-invasive THz imaging with improved sensitivity and specificity for translational clinical oncology. Nanoparticle contrast agent may enhance sensitivity and specificity of THz cancer imaging [Display omitted]